Two funds to profit from rising yields
The approval of the first coronavirus vaccine last November changed the investment landscape, with rising inflation expectations pushing ten-year US Treasury yields substantially higher.
The approval of the first coronavirus vaccine last November changed the investment landscape, with rising inflation expectations pushing ten-year US Treasury yields substantially higher.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Mark Watson-Mitchell is concerned that investors may be exhibiting irrational exuberance when it comes to certain areas of the market.
With a potential 120 billion barrels of oil equivalent on the table and an entire sedimentary basin in its hands, ReconAfrica might just be the oil play of the decade.
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small cap stocks…
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
China is becoming more assertive, even aggressive. But can we realistically rein in China’s excesses without risk, asks Victor Hill?
Robert Stephens, CFA, discusses the prospects for two FTSE 100 travel and leisure stocks – IAG and Whitbread.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Looking at this nearly two centuries old group, I have to say that I believe that its shares are significantly undervalued, writes Mark Watson-Mitchell.